We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Zebra Technologies
ZBRA
$12.6B
| $14.3M | 0.04% |
54,423
+26,900
| +98% | +$8.33M |
|
402
Crocs
CROX
$6.64B
| $14.2M | 0.04% |
206,900
-130,400
| -39% | -$9.05M |
|
403
Schwab US Dividend Equity ETF
SCHD
$103B
| $14.2M | 0.04% |
640,200
+60,600
| +10% | +$1.47M |
|
404
Tyler Technologies
TYL
$13.3B
| $14.1M | 0.04% |
40,600
-900
| -2% | -$335K |
|
405
Lincoln Electric
LECO
$13.9B
| $14.1M | 0.04% |
112,200
+20,700
| +23% | +$2.79M |
|
406
SAP
SAP
$202B
| $14M | 0.04% |
171,900
+152,100
| +768% | +$13.4M |
|
407
Revolve Group
RVLV
$1.83B
| $13.9M | 0.04% |
642,700
+169,300
| +36% | +$4.45M |
|
|
AYX
408
DELISTED
Alteryx Inc
AYX
| $13.8M | 0.04% |
247,400
+23,400
| +10% | +$1.37M |
|
409
Harmony Biosciences
HRMY
$2.08B
| $13.8M | 0.04% |
311,900
+74,900
| +32% | +$3.65M |
|
410
NovoCure
NVCR
$2.01B
| $13.8M | 0.04% |
181,800
-29,300
| -14% | -$2.29M |
|
411
Allison Transmission
ALSN
$9.97B
| $13.8M | 0.04% |
407,396
-204,800
| -33% | -$7.66M |
|
412
Corpay
CPAY
$25B
| $13.7M | 0.04% |
78,020
-19,900
| -20% | -$4.26M |
|
413
PTC Therapeutics
PTCT
$6.33B
| $13.7M | 0.04% |
+273,042
| New | +$13.4M |
|
|
RVNC
414
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13.7M | 0.04% |
507,500
+399,100
| +368% | +$8.1M |
|
415
United Microelectronic
UMC
$46.9B
| $13.7M | 0.04% |
2,456,400
+1,322,300
| +117% | +$8.73M |
|
416
Conagra Brands
CAG
$7.26B
| $13.7M | 0.04% |
+418,500
| New | +$14.4M |
|
417
Designer Brands
DBI
$296M
| $13.6M | 0.04% |
885,044
-149,000
| -14% | -$2.34M |
|
418
Vanguard Growth ETF
VUG
$215B
| $13.5M | 0.04% |
379,800
-108,000
| -22% | -$4.34M |
|
|
DVAX
419
DELISTED
Dynavax Technologies
DVAX
| $13.5M | 0.04% |
1,295,488
-386,800
| -23% | -$5.04M |
|
420
Ambarella
AMBA
$2.89B
| $13.4M | 0.04% |
239,300
+109,300
| +84% | +$8.1M |
|
421
Range Resources
RRC
$9B
| $13.4M | 0.04% |
531,800
-152,600
| -22% | -$4.62M |
|
422
Norwegian Cruise Line
NCLH
$8.92B
| $13.4M | 0.04% |
1,182,000
+823,900
| +230% | +$10.9M |
|
423
Photronics
PLAB
$1.73B
| $13.3M | 0.04% |
911,698
+64,100
| +8% | +$1.26M |
|
424
iShares Semiconductor ETF
SOXX
$42B
| $13.3M | 0.04% |
125,400
+102,639
| +451% | +$12.9M |
|
425
Teekay Tankers
TNK
$2.6B
| $13.2M | 0.04% |
480,570
+318,100
| +196% | +$7.52M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.